BIOMAT Database Logo BIOMAT Database Logo

Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. 1980

E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
High-activity heparin: chain length, affinity for antithrombin, and anticoagulant activity.
April 1982, Archives of biochemistry and biophysics,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
March 1984, Journal of biochemistry,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
July 1976, FEBS letters,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
February 1990, Thrombosis research,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
June 1982, Thrombosis and haemostasis,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
June 1987, The Biochemical journal,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
November 1984, Biochemistry,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
January 1980, Thrombosis research,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
February 1982, The Journal of pharmacology and experimental therapeutics,
E Holmer, and U Lindahl, and G Bäckström, and L Thunberg, and H Sandberg, and G Söderström, and L O Anderson
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
September 2000, Thrombosis research,
Copied contents to your clipboard!